{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T10:21:11Z","timestamp":1777026071560,"version":"3.51.4"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T00:00:00Z","timestamp":1676592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Dolby Foundation"},{"name":"UCL\/UCLH Biomedical Research"},{"name":"UCL Dementia Research Institute"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,19]]},"abstract":"<jats:p>Hardy and Mummery discuss the recent positive findings in the clinical trial of lecanemab in early Alzheimer\u2019s disease, and the implications for the amyloid hypothesis. They argue that the results mark a turning point for the Alzheimer\u2019s field, but that taking anti-amyloid therapies into clinical practice will be challenging.<\/jats:p>","DOI":"10.1093\/brain\/awad049","type":"journal-article","created":{"date-parts":[[2023,2,17]],"date-time":"2023-02-17T05:58:53Z","timestamp":1676613533000},"page":"1240-1242","source":"Crossref","is-referenced-by-count":51,"title":["An anti-amyloid therapy works for Alzheimer\u2019s disease: why has it taken so long and what is next?"],"prefix":"10.1093","volume":"146","author":[{"given":"John","family":"Hardy","sequence":"first","affiliation":[{"name":"Reta Lilla Weston Research Laboratories, UCL Institute of Neurology , London, WC1N 3BG , UK"},{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology , London, WC1N 3BG , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Mummery","sequence":"additional","affiliation":[{"name":"Department of Neurodegenerative Disease, UCL Institute of Neurology , London, WC1N 3BG , UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2023,2,17]]},"reference":[{"key":"2023041916423556600_awad049-B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2022","journal-title":"N Engl J Med"},{"key":"2023041916423556600_awad049-B2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.15252\/emmm.201606210","article-title":"The amyloid hypothesis of Alzheimer's disease at 25 years","volume":"8","author":"Selkoe","year":"2016","journal-title":"EMBO Mol Med"},{"key":"2023041916423556600_awad049-B3","first-page":"197","article-title":"Two randomized phase 3 studies of aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J Prev Alzheimers Dis"},{"key":"2023041916423556600_awad049-B4","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/s41573-022-00391-w","article-title":"The amyloid hypothesis in Alzheimer disease: New insights from new therapeutics","volume":"21","author":"Karran","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"2023041916423556600_awad049-B5","author":"S\u00f6derberg"},{"key":"2023041916423556600_awad049-B6","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00401-022-02433-4","article-title":"Alzheimer Disease neuropathology in a patient previously treated with aducanumab","volume":"144","author":"Plowey","year":"2022","journal-title":"Acta Neuropathol"},{"key":"2023041916423556600_awad049-B7","author":"Honig"},{"key":"2023041916423556600_awad049-B8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/NEN.0b013e31824b211b","article-title":"Accuracy of the clinical diagnosis of Alzheimer disease at national institute on aging Alzheimer disease centers, 2005\u20132010","volume":"71","author":"Beach","year":"2012","journal-title":"J Neuropathol Exp Neurol"},{"key":"2023041916423556600_awad049-B9","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neurobiolaging.2018.12.002","article-title":"Genetic analysis suggests high misassignment rates in clinical Alzheimer's cases and controls","volume":"77","author":"Escott-Price","year":"2019","journal-title":"Neurobiol Aging"},{"key":"2023041916423556600_awad049-B10","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1056\/NEJMc2215148","article-title":"Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke","volume":"388","author":"Reish","year":"2023","journal-title":"N Engl J Med"},{"key":"2023041916423556600_awad049-B11","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1056\/NEJMc2215907","article-title":"Response to: Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke","volume":"388","author":"Sabbagh","year":"2023","journal-title":"N Engl J Med"},{"key":"2023041916423556600_awad049-B12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","article-title":"Blood-based biomarkers for Alzheimer's disease: Towards clinical implementation","volume":"21","author":"Teunissen","year":"2022","journal-title":"Lancet Neurol"},{"key":"2023041916423556600_awad049-B13","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/ane.13628","article-title":"Blood biomarkers for Alzheimer's disease and related disorders","volume":"146","author":"Zetterberg","year":"2022","journal-title":"Acta Neurol Scand"},{"key":"2023041916423556600_awad049-B14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s13195-017-0312-4","article-title":"The Edinburgh consensus: Preparing for the advent of disease-modifying therapies for Alzheimer's disease","volume":"9","author":"Ritchie","year":"2017","journal-title":"Alzheimers Res Ther"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/brain\/advance-article-pdf\/doi\/10.1093\/brain\/awad049\/49592604\/awad049.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/146\/4\/1240\/50031470\/awad049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/brain\/article-pdf\/146\/4\/1240\/50031470\/awad049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T16:47:34Z","timestamp":1681922854000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/brain\/article\/146\/4\/1240\/7043510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,17]]},"references-count":14,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,2,17]]},"published-print":{"date-parts":[[2023,4,19]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awad049","relation":{},"ISSN":["0006-8950","1460-2156"],"issn-type":[{"value":"0006-8950","type":"print"},{"value":"1460-2156","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,4,3]]},"published":{"date-parts":[[2023,2,17]]}}}